Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.

Kowalski-Chauvel A, Gouaze-Andersson V, Baricault L, Martin E, Delmas C, Toulas C, Cohen-Jonathan-Moyal E, Seva C.

Cancers (Basel). 2019 Mar 22;11(3). pii: E406. doi: 10.3390/cancers11030406.

2.

IL13-Mediated Dectin-1 and Mannose Receptor Overexpression Promotes Macrophage Antitumor Activities through Recognition of Sialylated Tumor Cells.

Alaeddine M, Prat M, Poinsot V, Gouazé-Andersson V, Authier H, Meunier E, Lefèvre L, Alric C, Dardenne C, Bernad J, Alric L, Segui B, Balard P, Couderc F, Couderc B, Pipy B, Coste A.

Cancer Immunol Res. 2019 Feb;7(2):321-334. doi: 10.1158/2326-6066.CIR-18-0213. Epub 2019 Jan 4.

3.

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker.

Gouazé-Andersson V, Ghérardi MJ, Lemarié A, Gilhodes J, Lubrano V, Arnauduc F, Cohen-Jonathan Moyal E, Toulas C.

Oncotarget. 2018 Aug 3;9(60):31637-31649. doi: 10.18632/oncotarget.25827. eCollection 2018 Aug 3.

4.

Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1.

Kowalski-Chauvel A, Modesto A, Gouaze-Andersson V, Baricault L, Gilhodes J, Delmas C, Lemarie A, Toulas C, Cohen-Jonathan-Moyal E, Seva C.

Cell Death Dis. 2018 Aug 29;9(9):872. doi: 10.1038/s41419-018-0853-x.

5.

Targeting progastrin enhances radiosensitization of colorectal cancer cells.

Kowalski-Chauvel A, Gouaze-Andersson V, Vignolle-Vidoni A, Delmas C, Toulas C, Cohen-Jonathan-Moyal E, Seva C.

Oncotarget. 2017 Apr 20;8(35):58587-58600. doi: 10.18632/oncotarget.17274. eCollection 2017 Aug 29.

6.

FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway.

Gouazé-Andersson V, Delmas C, Taurand M, Martinez-Gala J, Evrard S, Mazoyer S, Toulas C, Cohen-Jonathan-Moyal E.

Cancer Res. 2016 May 15;76(10):3036-44. doi: 10.1158/0008-5472.CAN-15-2058. Epub 2016 Feb 19.

7.

Sphingolipid metabolism and drug resistance in hematological malignancies.

Gouaze-Andersson V, Cabot MC.

Anticancer Agents Med Chem. 2011 Nov;11(9):891-903. Review.

PMID:
21707483
8.

Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.

Gouazé-Andersson V, Flowers M, Karimi R, Fabriás G, Delgado A, Casas J, Cabot MC.

Prostate. 2011 Jul;71(10):1064-73. doi: 10.1002/pros.21321. Epub 2010 Dec 28.

PMID:
21557271
9.

P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Chapman JV, Gouazé-Andersson V, Karimi R, Messner MC, Cabot MC.

Exp Cell Res. 2011 Jul 15;317(12):1736-45. doi: 10.1016/j.yexcr.2011.03.004. Epub 2011 Mar 21.

10.

Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.

Chapman JV, Gouazé-Andersson V, Cabot MC.

Int J Oncol. 2010 Dec;37(6):1591-7.

PMID:
21042729
11.

Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.

Chapman JV, Gouazé-Andersson V, Messner MC, Flowers M, Karimi R, Kester M, Barth BM, Liu X, Liu YY, Giuliano AE, Cabot MC.

Biochem Pharmacol. 2010 Aug 1;80(3):308-15. doi: 10.1016/j.bcp.2010.04.001. Epub 2010 Apr 10.

12.

N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.

Wang H, Maurer BJ, Liu YY, Wang E, Allegood JC, Kelly S, Symolon H, Liu Y, Merrill AH Jr, Gouazé-Andersson V, Yu JY, Giuliano AE, Cabot MC.

Mol Cancer Ther. 2008 Sep;7(9):2967-76. doi: 10.1158/1535-7163.MCT-08-0549.

13.

A role for ceramide in driving cancer cell resistance to doxorubicin.

Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, Holleran WM, Giuliano AE, Jazwinski SM, Gouaze-Andersson V, Consoli DP, Cabot MC.

FASEB J. 2008 Jul;22(7):2541-51. doi: 10.1096/fj.07-092981. Epub 2008 Feb 1.

PMID:
18245173
14.

Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.

Gouazé-Andersson V, Yu JY, Kreitenberg AJ, Bielawska A, Giuliano AE, Cabot MC.

Biochim Biophys Acta. 2007 Dec;1771(12):1407-17. Epub 2007 Nov 9.

15.

Glycosphingolipids and drug resistance.

Gouaze-Andersson V, Cabot MC.

Biochim Biophys Acta. 2006 Dec;1758(12):2096-103. Epub 2006 Aug 26. Review.

Supplemental Content

Loading ...
Support Center